221
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Surface Enhanced Laser Desorption/Ionization (SELDI) Time-of-Flight Mass Spectrometry to Identify Patients with Chronic Obstructive Pulmonary Disease

, &
Pages 41-50 | Published online: 02 Jul 2009

REFERENCES

  • Mannino D M, Homa D M, Akinbami L J, Ford E S, Redd S C. Chronic obstructive pulmonary disease surveillance–United States, 1971–2000. MMWR Surveill Summ 2002; 51(6)1–16, [CSA]
  • Sullivan S D, Ramsey S D, Lee T A. The economic burden of COPD. Chest 2000; 117(2 Suppl)5S–9S, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Shigeoka J W, Hall W J, Hyde R W, Schwartz R H, Mudholkar G S, Speers D M, Lin C C. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease. Am Rev Respir Dis 1976; 114(6)1077–1084, [PUBMED], [INFOTRIEVE], [CSA]
  • Eriksson S. Studies in alpha 1-antitrypsin deficiency. Acta Med Scand Suppl 1965; 432: 1–85, [PUBMED], [INFOTRIEVE], [CSA]
  • Lieberman J, Winter B, Sastre A. Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest 1986; 89(3)370–373, [PUBMED], [INFOTRIEVE], [CSA]
  • Vlahou A, Schorge J O, Gregory B W, Coleman R L. Diagnosis of Ovarian Cancer Using Decision Tree Classification of Mass Spectral Data. J Biomed Biotechnol 2003; 2003(5)308–314, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Moshkovskii S A, Serebryakova M V, Kuteykin-Teplyakov K B, Tikhonova O V, Goufman E I, Zgoda V G, Taranets I N, Makarov O V, Archakov A I. Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. Proteomics, 2005
  • Semmes O J, Feng Z, Adam B L, Banez L L, Bigbee W L, Campos D, Cazares L H, Chan D W, Grizzle W E, Izbicka E, Kagan J, Malik G, McLerran D, Moul J W, Partin A, Prasanna P, Rosenzweig J, Sokoll L J, Srivastava S, Srivastava S, Thompson I, Welsh M J, White N, Winget M, Yasui Y, Zhang Z, Zhu L. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem 2005; 51(1)102–112, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Liu W, Guan M, Wu D, Zhang Y, Wu Z, Xu M, Lu Y. Using tree analysis pattern and SELDI-TOF-MS to discriminate transitional cell carcinoma of the bladder cancer from noncancer patients. Eur Urol 2005; 47(4)456–462, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Yang S Y, Xiao X Y, Zhang W G, Zhang L J, Zhang W, Zhou B, Chen G, He D C. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer 2005; 5: 83, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Cadieux P A, Beiko D T, Watterson J D, Burton J P, Howard J C, Knudsen B E, Gan B S, McCormick J K, Chambers A F, Denstedt J D, Reid G. Surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis. J Clin Lab Anal 2004; 18(3)170–175, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Zhu X D, Zhang W H, Li C L, Xu Y, Liang W J, Tien P. New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology. World J Gastroenterol 2004; 10(16)2327–2329, [PUBMED], [INFOTRIEVE], [CSA]
  • Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood D E. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348(21)2059–2073, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Fabbri L M, Hurd S S. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J 2003; 22(1)1–2, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Breiman L. Classification and regression trees. The Wadsworth statistics/probability series, Wadsworth International Group, Belmont, Calif 1984
  • Rai A J, Stemmer P M, Zhang Z, Adam B L, Morgan W T, Caffrey R E, Podust V N, Patel M, Lim L Y, Shipulina N V, Chan D W, Semmes O J, Leung H C. Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: Multi-institution correlation of spectra and identification of biomarkers. Proteomics 2005; 5(13)3467–3474, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Hersh C P, Demeo D L, Lange C, Litonjua A A, Reilly J J, Kwiatkowski D, Laird N, Sylvia J S, Sparrow D, Speizer F E, Weiss S T, Silverman E K. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol 2005; 33(1)71–78, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Ross G, Bever F N, Uddin Z, Hockman E M. Troponin I sensitivity and specificity for the diagnosis of acute myocardial infarction. J Am Osteopath Assoc 2000; 100(1)29–32, [PUBMED], [INFOTRIEVE], [CSA]
  • Carrette O, Demalte I, Scherl A, Yalkinoglu O, Corthals G, Burkhard P, Hochstrasser D F, Sanchez J C. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. Proteomics 2003; 3(8)1486–1494, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Lewczuk P, Esselmann H, Groemer T W, Bibl M, Maler J M, Steinacker P, Otto M, Kornhuber J, Wiltfang J. Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease. Biol Psychiatry 2004; 55(5)524–530, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Vehmas A K, Borchelt D R, Price D L, McCarthy D, Wills-Karp M, Peper M J, Rudow G, Luyinbazi J, Siew L T, Troncoso J C. beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology. DNA Cell Biol 2001; 20(11)713–721, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Lewczuk P, Esselmann H, Meyer M, Wollscheid V, Neumann M, Otto M, Maler J M, Ruther E, Kornhuber J, Wiltfang J. The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide. Rapid Commun Mass Spectrom 2003; 17(12)1291–1296, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Davies H, Lomas L, Austen B. Profiling of amyloid beta peptide variants using SELDI Protein Chip arrays. Biotechniques 1999; 27(6)1258–1261, [PUBMED], [INFOTRIEVE], [CSA]
  • Bowler R P, Duda B, Chan E D, Enghild J J, Ware L B, Matthay M A, Duncan M W. Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004; 286(6)L1095–1104, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Baggerly K A, Morris J S, Coombes K R. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 2004; 20(5)777–785, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Ripley B D. Pattern recognition and neural networks. Cambridge University Press, Cambridge; New York 1996; 403
  • Hand D J, Mannila H, Smyth P. Principles of data mining. Adaptive computation and machine learning. MIT Press, Cambridge, Mass. 2001
  • Cristianini N, Shawe-Taylor J. An introduction to support vector machines: and other kernel-based learning methods. New York Cambridge University Press. 2000
  • Orengo C, Jones D, Thornton J M. Bioinformatics: Genes, Proteins and Computers. Oxford, Oxford New York 2003
  • Verma M, Wright G L, Jr., Hanash S M, Gopal-Srivastava R, Srivastava S. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Ann NY Acad Sci 2001; 945: 103–115, [PUBMED], [INFOTRIEVE], [CSA]
  • Grizzle W E, Semmes O J, Basler J, Izbicka E, Feng Z, Kagan J, Adam B L, Troyer D, Srivastava S, Thornquist M, Zhang Z, Thompson I M. The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: A study in biomarker validation in genitourinary oncology. Urol Oncol 2004; 22(4)337–343, [PUBMED], [INFOTRIEVE], [CSA]
  • Zolotarjova N, Martosella J, Nicol G, Bailey J, Boyes B E, Barrett W C. Differences among techniques for high-abundant protein depletion. Proteomics 2005; 5(13)3304–3313, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.